Trial Profile
An Observational Cohort Study on Transplant-Related Mortality in Patients Receiving Either a Hematopoietic Stem Cell Transplantation Without ATIR or an Umbilical Cord Blood Transplantation
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs T cell replacement therapy (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Kiadis Pharma
- 06 Nov 2019 Results of pooled post-hoc analysis assesing overall survival by using data from three studies including this study released in the 61st Annual Meeting and Exposition of the American Society of Hematology.
- 05 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 May 2015 as reported by ClinicalTrials.gov record.